Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Adalimumab improved folliculitis decalvans in most patients.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Tofacitinib helped regrow hair in most patients with severe hair loss.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

A new microneedle patch effectively and safely treats alopecia areata.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

A patient lost all their hair while on rheumatoid arthritis medication.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Upadacitinib may effectively treat resistant lichen planopilaris.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Candida antigen is an effective and promising treatment for alopecia areata.